Effect of alpha-lipoic acid on blood glucose, insulin resistance, and glutathione peroxidase of type 2 diabetic patients

Saudi Medical Journal

Volumn 32, Issue 6, 2011, Pages 584-588

  Ansar, Hasti ^a   Mazloom, Zohreh ^a   Kazemi, Fatemeh ^a   Hejazi, Najmeh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; PLACEBO; THIOCTIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PLACEBOS; THIOCTIC ACID;

EID: 79959287922     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 (Suppl 1): S5-S10.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
3. Hannon-Fletcher MP, O'Kane MJ, Moles KW, Weatherup C, Barnett CR, Barnett YA. Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. Mutat Res 2000; 460: 53-60.
4. Sasvári M, Nyakas C. Time dependent changes in oxidative metabolism during chronic diabetes in rats. Acta Biologica Szegediensis 2003; 47: 153-158.
5. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009; 202: 321-329.
6. Evans JL, Maddux B, Goldfine ID. Antioxidant in diabetic complications and insulin resistance. In: Raz I, Skyler J, Shafrir E, editors. From Research to Diagnosis and Treatment. London (UK): Informa Healthcare; 2003. p. 479-496.
7. Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones 2006; 5: 251-258.
8. Rosen P, Tritschler HJ. Vascular complications in diabetes: Mechanisms and the influence of antioxidants. In: Packer L, Cadenas E, editors. Handbook of antioxidants. California: CRC; 2000; p. 511-533.
9. Dicter N, Madar Z, Tirosh O. Alpha-lipoic acid inhibits glycogen synthesis in rat soleus muscle via its oxidative activity and the uncoupling of mitochondria. J Nutr 2002; 132: 3001-3006.
10. Vessal M, Hemmati M, Vasie M. Antidiabetic effects of quercetinin in streptozotocininduced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003; 135: 357-364.
11. El-Hossary GG, El-Shazly HM, Ahmed NS, El-Gohary AA, Metwally FG, Karam SH. Efficacy of alpha-lipoic acid against diabetes-Induced deterioration of blood antioxidants and diabetic retinopathy in experimental animals. Aust J Basic Appl Sci 2010; 4: 127-134.
12. Eason RC, Archer HE, Akhtar S, Bailey CJ. Lipoic acid increases glucose uptake by skeletal muscles of obese-diabetic ob/ob mice. Diabetes Obes Metab 2002; 4: 29-35.
13. Bitar MS, Wahid S, Pilcher CW, Al-Saleh E, Al-Mulla F. Alphalipoic acid mitigates insulin resistance in Goto-Kakizaki rats. Horm Metab Res 2004; 36: 542-549.
14. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, et al. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 2001; 50: 1464-1471.
15. Moini H, Tirosh O, Park YC, Cho KJ, Packer L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch Biochem Biophys 2002; 397: 384-391.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
17. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 2000; 43: 294-303.
18. Balkis Budin S, Othman F, Louis SR, Abu Bakar M, Radzi M, Osman K, et al. Effect of alpha lipoic acid on oxidative stress and vascular wall of diabetic rats. Rom J Morphol Embryol 2009; 50: 23-30.
19. Winiarska K, Malinska D, Szymanski K, Dudziak M, Bryla J. Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits. Biochimie 2008; 90: 450-459.
20. El-Midaoui A, de Champlain J. Prevention of hypertension, Insulin Resistance, and oxidative stress by alpha-Lipoic Acid. Hypertension 2002; 39: 303-307.
21. Konrad D. Utilization of the insulin-signaling network in the metabolic actions of alpha-lipoic acid-reduction or oxidation? Antioxid Redox Signal 2005; 7: 1032-1039.
22. Saengsirisuwan V, Kinnick TR, Schmit MB, Henriksen EJ. Interactions of exercise training and lipoic acid on skeletal muscle glucose transport in obese Zucker rats. J Appl Physiol 2001; 91: 145-153.
23. Poh ZX, Goh KP. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets 2009; 9: 392-398.
24. Walgren JL, Amani Z, McMillan JM, Locher M, Buse MG. Effect of R(+) alpha-lipoic acid on pyruvate metabolism and fatty acid oxidation in rat hepatocytes. Metabolism 2004; 53: 165-173.
25. Muellenbach EM, Diehl CJ, Teachey MK, Lindborg KA, Archuleta TL, Harrella NB, et al. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat. Metabolism 2008; 57: 1465-1472.
26. de Oliveira AM, Rondó PH, Luzia LA, D'abronzo FH, Illison VK. The effects of lipoic acid and _-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: A randomized, double-blind, placebocontrolled trial. Diabetes Res Clin Pract 2011 Mar 1.
27. Ahmed FN, Naqvi FN, Shafiq F. Lipid Peroxidation and Serum Antioxidant Enzymes in Patients with Type 2 Diabetes Mellitus. Ann N Y Acad Sci 2006; 1084: 481-489.
28. Likidlilid A, Patchanans N, Poldee S, Peerapatdit T. Glutathione and glutathione peroxidase in type 1 diabetic patients. J Med Assoc Thai 2007; 90: 1759-1767.
29. Bolajoko EB, Mossanda KS, Adeniyi F, Akinosun O, Fasanmade A, Moropane M. Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. S Afr Med J 2008; 98: 614-617.
30. Dincer Y, Akcay T, Alademir Z, Ilkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002; 51: 1360-1362.